THOMAS HAGERMAN: Open Payments
NPI 1891329975 · WILLIAMSON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 86 payments from 12 companies in 2025. Trend: 2023 $704 · 2024 $897 · 2025 $1,541
Food & beverage: $1,541
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $655 |
| Janssen Biotech, Inc. | 18 | $262 |
| UCB, Inc. | 7 | $177 |
| PFIZER INC. | 7 | $164 |
| GENZYME CORPORATION | 4 | $97 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| Galderma Laboratories, L.P. | 2 | $38 |
| Smith+Nephew, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: SKYRIZI, TREMFYA, RINVOQ, Bimzelx, CIBINQO, DUPIXENT, LITFULO, Zoryve.
Industry payments across WV — which companies pay providers there.
